Smart for Life (SMFL) Announces Letter of Intent to Acquire Largest Acquisition to Date.
6th Acquisition to Date is Expected to Add over $15 million of Revenue and to be Accretive to Earnings.
Stated goal of $100 million in...
Revive (RVVTF) Hits a Snag?
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
First our summary."FDA provided communication that the amended protocol is still under...
Revive Therapeutics (RVVTF) Annual Shareholder Meeting.
ANNUAL SHAREHOLDER MEETING
https://vimeo.com/752050831
CORPORATE PRESENTATION | AUGUST 2022
NEWS ARCHIVE
13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)
RAPS' Latest | 01 August 2019 | By Zachary Brousseau
When the US Food and Drug Administration (FDA) has significant questions or concerns about clinical data...
Adding Progressive Care (RXMD) $0.04 to Watch List.
Adding to Biotech Stock Review 2022 Watch List.
Speculative, Yes. But Pay Down of $2 Million Toxic Note and Move into Remote Patient Monitoring Makes...
CB Scientific, Inc. (CBSC) Announces FDA 510(k) Submission.
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
Updated product to include significant operating improvements and material design advances over...
Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules Capital
Don't think we've ever seen anything like this before. Most investors who prefer to invest post FDA approval, invest post FDA approval. They got...
Is There Enough Monkeypox (Mpox) Vaccine to go Around? Maybe yes, More Likely no.
Reported in Gates and Soda
As monkeypox cases continue to mount – topping 31,000 cases globally – governments of wealthy nations have been scrambling to...
Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...
VERU Inc. (VERU) $24. High Risk, Minimal Reward?
Pre-FDA Approval Play. The Shares Are Now in the Hands of Fast Money Traders.
You Can't Kiss all the Pretty Girls, But Revive Therapeutics (RVVTF)...
Latest article
Adding Brixton Metals (BBBXF) $0.05 to the Watch List.
Having Dinner With Management Tomorrow, We'll be Back With What we Learn.
In the meantime, we are adding Brixton Metals (BBBXF) to the Watch...
United States Antimony (UAMY) on Fox News.
DALLAS, TX / ACCESS Newswire / June 4, 2025 / United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE American: UAMY), announced today that its Chairman...
Institutional Analyst: Latest Newsletter.
Biotechnology, Beverages, Precious Metals, Psychedelics, and Technology.
Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources...
